Greenspring Advisors »

Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Greenspring Advisors

Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Greenspring Advisors from 13F filings

Historical chart of Greenspring Advisors investment in Sarepta Therapeutics Inc Note 1.250 9/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by Greenspring Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by Greenspring Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $13k 14k 0.95

More positions owned by Greenspring Advisors

Dimensional Etf Trust Us Cor Equ 2 Etf (DFAC)
Dimensional Etf Trust Intl Core Equity (DFIC)
Ishares Tr Core Us Aggbd Et (AGG)
Dimensional Etf Trust Emerging Mkts Co (DFEM)
Dimensional Etf Trust World Ex Us Core (DFAX)
Dimensional Etf Trust Us High Prof Etf (DUHP)
Dimensional Etf Trust Us Equi Mark Etf (DFUS)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
American Centy Etf Tr Us Eqt Etf (AVUS)
Ishares Tr Russell 3000 Etf (IWV)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
Apple (AAPL)
American Centy Etf Tr Avantis All Eqt (AVGE)
Vanguard Index Fds Total Stk Mkt (VTI)

View all positions for Greenspring Advisors

Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1

Highbridge Capital Management
DeepCurrents Investment Group
D. E. Shaw & Co
LMR Partners
Calamos Advisors
Corbyn Investment Management
Oaktree Capital Management
Bnp Paribas Investment Partners
Russell Investments
FMR
Financial Consulate
Advent Capital Management
Jpmorgan Chase & Co
Morgan Stanley
HB Wealth Management

View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1